Integrated Diagnostics Holdings plc
IDGXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $12 | $13 | $11 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $10 | $12 | $13 | $11 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 0% | 10% | 0% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 42% | 42% | 39% | 39% |
| EBITDA | $1 | $1 | $0 | $0 |
| % Margin | 30.2% | 30.2% | 29.1% | 29.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 15.6% | 15.6% | 17% | 17% |
| EPS Diluted | 0.47 | 0.47 | 0.47 | 0.47 |
| % Growth | 0% | 0% | 0% | – |
| Operating Cash Flow | $0 | $0 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |